Healthcare provider profile · identity verified

Brian J Pickett, MD

Allopathic & Osteopathic Physicians|Internal Medicine · CRANSTON, RI · NPI 1497828628

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Brian J Pickett, MD received $87.80 in general payments during 2025 across 2 reported records.

Solventum Corporation accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$87.80

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Solventum Corporation	Unresolved — no canonical attribution shown	$87.80	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$87.80	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ACTIV.A.C. Normalized: activ a c	Device	Solventum Corporation	$87.80	2	2025
Source payment records 2025-06-23 · Solventum Corporation · $22.04 · Open Payments source 2025-08-25 · Solventum Corporation · $65.76 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	792	225
Amlodipine Besylate	Amlodipine Besylate	542	158
Omeprazole	Omeprazole	364	104
Lisinopril	Lisinopril	326	89
Levothyroxine Sodium	Levothyroxine Sodium	284	67
Losartan Potassium	Losartan Potassium	223	66
Alprazolam	Alprazolam	202	43
Escitalopram Oxalate	Escitalopram Oxalate	200	54
Tamsulosin Hcl	Tamsulosin Hcl	196	55
Simvastatin	Simvastatin	189	51
Rosuvastatin Calcium	Rosuvastatin Calcium	185	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	179	29
Tramadol Hcl	Tramadol Hcl	178	33
Albuterol Sulfate Hfa	Albuterol Sulfate	155	46
Trazodone Hcl	Trazodone Hcl	153	36
Zolpidem Tartrate	Zolpidem Tartrate	151	24
Pantoprazole Sodium	Pantoprazole Sodium	150	49
Metoprolol Succinate	Metoprolol Succinate	146	42
Glipizide-Metformin	Glipizide/Metformin Hcl	137	30
Olmesartan Medoxomil	Olmesartan Medoxomil	125	34
Eliquis	Apixaban	112	23
Sertraline Hcl	Sertraline Hcl	110	27
Jardiance	Empagliflozin	109	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	108	28
Metoprolol Tartrate	Metoprolol Tartrate	105	32
Famotidine	Famotidine	103	30
Pravastatin Sodium	Pravastatin Sodium	102	23
Hydrochlorothiazide	Hydrochlorothiazide	99	30
Fluticasone Propionate	Fluticasone Propionate	98	29
Ibuprofen	Ibuprofen	97	29
Montelukast Sodium	Montelukast Sodium	97	26
Finasteride	Finasteride	96	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	27
Meloxicam	Meloxicam	96	34
Valsartan	Valsartan	96	25
Duloxetine Hcl	Duloxetine Hcl	94	19
Gabapentin	Gabapentin	92	23
Allopurinol	Allopurinol	84	22
Metformin Hcl	Metformin Hcl	80	26
Metformin Hcl Er	Metformin Hcl	80	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	79	12
Ezetimibe	Ezetimibe	74	24
Oxycodone Hcl	Oxycodone Hcl	74	16
Xarelto	Rivaroxaban	72	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	69	17
Alendronate Sodium	Alendronate Sodium	65	18
Lorazepam	Lorazepam	64	20
Temazepam	Temazepam	62	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	18
Clonazepam	Clonazepam	60	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	59	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	17
Citalopram Hbr	Citalopram Hydrobromide	52	13
Naproxen	Naproxen	52	16
Furosemide	Furosemide	50	22
Glimepiride	Glimepiride	49	14
Glipizide	Glipizide	46	13
Prednisone	Prednisone	46	29
Triamcinolone Acetonide	Triamcinolone Acetonide	44	23
Warfarin Sodium	Warfarin Sodium	44	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	43	suppressed
Pregabalin	Pregabalin	43	suppressed
Methylprednisolone	Methylprednisolone	41	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	32
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Atenolol	Atenolol	37	suppressed
Carvedilol	Carvedilol	37	12
Potassium Chloride	Potassium Chloride	37	suppressed
Diazepam	Diazepam	36	11
Eszopiclone	Eszopiclone	35	19
Synthroid	Levothyroxine Sodium	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Ozempic	Semaglutide	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Bumetanide	Bumetanide	29	11
Ondansetron Hcl	Ondansetron Hcl	29	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	24
Valacyclovir	Valacyclovir Hcl	27	12
Fenofibrate	Fenofibrate,micronized	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Cefdinir	Cefdinir	19	19
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Azithromycin	Azithromycin	16	14
Carisoprodol	Carisoprodol	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Belsomra	Suvorexant	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$87.80 · 2 records	Solventum Corporation	ACTIV.A.C.	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error